PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment

PRECISION is an initiative from the Belgian Society of Medical Oncology (BSMO) in collaboration with several stakeholders, encompassing four programs that aim to boost genomic and clinical knowledge with the ultimate goal to offer patients with metastatic solid tumors molecularly guided treatments. The PRECISION 1 study has led to the creation of a clinico-genomic database. The Belgian Approach for Local Laboratory Extensive Tumor Testing (BALLETT) and GeNeo studies will increase the number of patients with advanced cancer that have comprehensive genotyping of their cancer. The PRECISION 2 pro... Mehr ...

Volltext
Verfasser: Thouvenin, J.
Van Marcke, C.
Decoster, L.
Raicevic, G.
Punie, K.
Vandenbulcke, M.
Salgado, R.
Van Valckenborgh, E.
Maes, B.
Joris, S.
Vander Steichel, D.
Vranken, K.
Jacobs , S.
Dedeurwaerdere, F.
Martens, G.
Devos, H.
Duhoux, F. P.
Rasschaert, M.
Pauwels , P.
Geboes, K.
Collignon, J.
Tejpar, S.
Canon, J-L
Peeters, M.
Rutten, A.
Van de Mooter, T.
Vermeij, J.
Schrijvers, D.
Demey, W.
Lybaert, W.
Van Huysse, J.
MEBIS, Jeroen
Awada, A.
Claes, K. B. M.
Hebrant, A.
Van der Meulen, J.
Delafontaine, B.
Vanden Bempt, I
Maetens, J.
de Hemptinne, M.
Rottey, S.
Aftimos, P.
De Greve, J.
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Verlag/Hrsg.: ELSEVIER
Schlagwörter: next-generation sequencing (NGS) / metastatic tumors / genomic alterations genomic-driven therapy / genomic-driven therapy / molecular tumor board
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26529457
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : http://hdl.handle.net/1942/38837